Aurinia Pharmaceuticals (AUPH) Stock
Aurinia Pharmaceuticals (AUPH) closed at $15.40 on Nov 17, 2026; its Tenet Score is 82 of 100 against 340 Healthcare peers.
8 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $15.40
- Nov 17, 2026
- Market cap
- $2.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 6.7×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 13.52 – 19.25
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 82/100
- Strong · 340 Healthcare peers
Industry: Drugs
Aurinia Pharmaceuticals Inc scores 82/100. Strong. Strongest on growth and value, trading at 7× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ~ Piotroski F-Score
- ✓ Munger Compounders
- ✓ Magic Formula
- ~ Graham Defensive
- ✕ Quality Compounder
13F flows & insider trades land here.
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the t…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Perrigo Company plcPRGO | 40 | $2.3B |
| Celldex Therapeutics Inc.CLDX | 44 | $2.2B |
| Beam Therapeutics IncBEAM | 61 | $2.2B |
| Immunome IncIMNM | 49 | $2.1B |
| Schrodinger IncSDGR | 41 | $2.1B |
| Vera Therapeutics IncVERA | 41 | $1.9B |
| Veracyte IncVCYT | 77 | $1.9B |
| Harmony Biosciences Holdings IncHRMY | 81 | $1.9B |
| Maravai LifeSciences Holdings IncMRVI | 29 | $1.9B |
| Biocryst Pharmaceuticals Inc.BCRX | 72 | $1.9B |
Common questions
What sector and industry is Aurinia Pharmaceuticals in?
Aurinia Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Aurinia Pharmaceuticals' Tenet Score?
Aurinia Pharmaceuticals' Tenet Score is 82 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




